98%
921
2 minutes
20
A rapid, in-field, and reliable method for the detection of illegal drugs of abuse in biological fluids without any sample pretreatment would potentially be helpful for law enforcement, drug control officials, and public healthcare. In this study, we presented a cost-effective and highly reproducible solution-based surface-enhanced Raman scattering (SERS) platform utilizing a portable Raman instrument for fast sensitive SERS detection of illegal drugs, such as cocaine, and heroin in human urine without any sample preprocessing. The SERS platform was constructed for the first time by combining the superior SERS enhancement properties of bimetallic silver-coated gold nanostars (BGNS-Ag) and the advantages of suitable alkaline metal salts such as NaI for SERS signal amplification. The effects of the silver thickness of BGNS-Ag and alkaline salts on the SERS performance were investigated in detail; we observed that the maximum SERS enhancement was obtained for BGNS-Ag with the maximum silver thickness (54 ± 5 nm) in presence of NaI salt. Our SERS platform shows ultra-high sensitivity of cocaine and heroin with a limit of detection (LOD) as low as 10 pg/mL for cocaine and 100 pg/mL for heroin, which was 100 times lower than that of the traditional silver nanoparticle-based illegal drug detection. As a demonstration, the platform was further applied to detect cocaine and heroin spiked in human urine without any sample preprocessing achieving a LOD of 100 pg/mL for cocaine and 1 ng/mL for heroin. Overall, our SERS detection platform shows potential for rapid, onsite, ultra-low-cost portable applications for trace detection of illegal drugs and biomarkers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.aca.2023.340956 | DOI Listing |
Am J Lifestyle Med
September 2025
Center for Behavioral Emergency & Addiction Research, McWilliams School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA (ASC, MCT, AL, TCL).
Background: Substance use disorders (SUD) are associated with metabolic dysregulation and nutritional deficiencies. Studies show that incorporating nutrition interventions into treatment may improve physical and psychological health. This study sought to explore dietary and consumer behavior in individuals currently using substances.
View Article and Find Full Text PDFBMC Public Health
August 2025
School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Objective: To synthesize and determine the relative effectiveness of diverse opioid agonist treatment (OAT) medications, including injectables, for opioid use disorder (OUD).
Methods: We searched EMBASE, PubMed, and CENTRAL for Randomised Controlled Trials (RCTs) (CRD42018109469) and previously published systematic reviews of head-to-head trials of OAT medications. The primary outcome was treatment retention, and secondary outcomes included days of opioid use, days of cocaine use, and proportion of participants involved in criminalized activities.
Sci Rep
August 2025
Department of Analytical Chemistry, Faculty of Chemistry, K.N. Toosi University of Technology, Postal Code, P.O. Box 16315-1618, Tehran, 15418-49611, Iran.
In this study, the effects of the induced magnetic field on the separation of drugs with different structures and polarities were investigated. Herein, column chromatography within an induced magnetic field was introduced to examine the influence of magnetic fields on materials and their interactions. For this purpose, the drugs were categorized into three series based on polarity: tramadol (logP 1.
View Article and Find Full Text PDFNiger J Clin Pract
August 2025
Department of Parasitology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Türkiye.
Background: Toxoplasma gondii is a common parasitic infection agent that, in its chronic phase, forms persistent tissue cysts in neuronal cells, potentially leading to neurological and behavioral alterations.
Aim: To investigate the role of chronic toxoplasmosis in human substance abuse and investigate its effect on dopamine levels, which is associated with substance abuse.
Materials And Methods: The study was designed with a substance abuse group comprising 90 patients with substance addiction and a control group consisting of 75 individuals without substance addiction.
Front Pediatr
August 2025
Tufts Clinical and Translational Science Institute, Boston, MA, United States.
Objective: Development and validation of a clinical prediction model for receipt of pharmacotherapy for Neonatal Abstinence Syndrome (NAS).
Study Design: Data from three cohorts included opioid exposed neonates ≥37 weeks gestation. Primary outcome was the receipt of pharmacotherapy utilizing a modified Finnegan Neonatal Abstinence Scoring System (FNASS).